Bristol Myers Squibb

Bristol Myers Squibb's organizational structure includes business units and subsidiaries led by a leadership team spanning multiple corporate functions. Under the company's leadership, Chris Boerner serves as Board Chair and Chief Executive Officer, Lynelle Hoch is President of the Cell Therapy Organization, Kenneth Thress is an Executive Director, and Colin Godwin also holds the title of Executive Director. The organization is further defined by specialized functions, starting with a regional unit in the United Kingdom, where clinical services include the medicine sub-function led by Executive Medical Director Sidonie Hartridge-Lambert. The Information Technology function is headed by Greg Meyers as Executive Vice President, Chief Digital and Technology Officer and Member of the Executive Committee, with additional IT leaders including Teodoro Fernandez (Executive Director, Digital/IT, Cell Therapy Manufacturing Operations), Myra Abousabe (Executive Director, Patient Safety, Business Insights and Technology), Pete Ciabattoni (Executive Director, Global Product Development and Supply Enterprise Functions IT), Michael Sullivan (Executive Director, Global Development Operations, Business Insights and Technology), Michael R. (Executive Director, Head of IT, Market Access), Paul Heffernan (Executive Director, Corporate IT), Sugandha Gupta (Executive Director, Digital Workforce Technology and Experience), Al Wang (Executive Director, Emerging Methods and Technologies, Research IT), and Christine Kerwick (Executive Director, IT Finance). Within IT, the Application Development sub-function includes Brendan Mack as Executive Director of Analytics Development for GPS. The Data Management and Analytics function includes Brendan Mack again, along with Myra Abousabe, Michael Livecchi, Mariann Micsinai-Balan (Executive Director, Head of Data Science), Neelima Thanneer (Executive Director, Head of Data Science, Pharmacometric Programming and PK Analysis and Reporting), and Sarah Chang (Executive Director, Clinical Data Acquisition); within the Data Science sub-function, Mariann Micsinai-Balan and Neelima Thanneer are listed. The Information Security function is led by Sydney Klein as Senior Vice President, Chief Information Security Officer, and Head of Enterprise IT, and includes Ari Hamalian (Executive Director, IT Risk Operations and Supplier Resilience). The Data Privacy & Security sub-function under Sydney Klein includes Erica Davila (Senior Vice President, Chief Privacy Officer, AI, Data, Privacy Law and Compliance), and Jonathan Daniels (Klein) (Executive Director, Global Head of Privacy Law and Compliance) reports under Davila. The Digital Transformation and Innovation function includes Rhonda Spraker Griscti (Executive Director, Digital Strategy and Global Process Lead), Seemi Kazmi (Executive Director, Digital Health, Therapeutic Area Lead, Cardiovascular and Neuroscience), Vikas Dua (Executive Director, Digital and IT, Product Development and Digital Manufacturing), and Sharon Liang (Executive Director, Head of Precision Medicine and Digital Health). The AI/ML function includes Stephen Fox as Executive Director of Analytics and AI Enablement. IT Service Management (ITSM) includes Jim Droney (Executive Director, End User Technology Services), and IT Operations Management (ITOM) includes Nelson Novoa (Executive Director, Information Technology, Hosting Operations). The Strategy function has leaders including Rhonda Spraker Griscti, Eric Luque, Maurice Bellfield, Megan Morin, Michael Livecchi, Samy Jalil Montoya, William H. Bullock, Laurent Lehmann, Suzie Lee C., Lisa McDonald, Irene Mac, and Shannon Higgins-Gruber; the Corporate Strategy sub-function additionally lists Irene Mac as Executive Director, Corporate Strategy. The Finance function includes David Elkins as Executive Vice President and Chief Financial Officer, Global Business Operations, with Bancroft Charles as Group Chief Financial Officer, Tomas Bohman as CFO for Global Research and Development and SVP Finance, and directors including Michael Livecchi, Chris Szymborski, Jared Scott (Executive Director, Research and Development Finance Operations). The Internal Audit sub-function under Finance is led by Fawad Shamshad (Senior Vice President, Chief Audit Officer) and Sharon Greenlees (Senior Vice President, Corporate Controller and Chief Audit Officer). The Governance, Risk, and Compliance (GRC) function includes Taylor Ocasio (Executive Director, Assistant General Counsel, Corporate Governance, Enterprise Strategy and Assistant Corporate Secretary) and Robert Schneller (Executive Director, Enterprise Governance). The Legal function includes the Regulatory Affairs sub-function with Maria Wagner (Executive Director, Global Regulatory Sciences and Business Operations), Dan Robison (Executive Director, Government Pricing, Global Market Access, Pricing and Value Demonstration), and Kevin Tompkins (Executive Director, Head of Regulatory Information and Submission Management); and the Contracts sub-function includes Linda Kamin (Executive Director, Contract Operations and Government Reporting, Bristol-Myers Squibb). The Human Resources function is led by Amanda Poole as Chief People Officer and Fernando Salinas as Chief Talent and Inclusion Officer, with the Talent Acquisition sub-function including Dante Maiden (Executive Director, Global Talent Sourcing and Engagement) and Fernando Salinas, and the DEI sub-function including Fernando Salinas. The Sales function is headed by Adam Lenkowsky as Executive Vice President and Chief Commercial Officer, with Laurent Lehmann listed under it; the Pricing and Quoting sub-function includes Dan Robison, and the Sales Operations sub-function includes Anthony Certo (Executive Director, Sales Operations). The Risk Management function includes Brian Bittmann (Executive Director, Operational Risk Assessment and Oversight), Lorna Charles (Executive Director, Worldwide Patient Safety), and Michael Cheung (Executive Director, Global Risk Management, REMS and Risk Management Strategy). The Research & Development function is led by Robert Plenge (Executive Vice President, Chief Research Officer, Head of Research) and includes Sameen Desai (Executive Director, R&D, Patient Safety and Therapeutic Areas), William H. Bullock, Suzie Lee C., Stephan O. Krause, PhD (Executive Director, Analytical Science and Technology, Cell Therapy Quality), Lisa McDonald, Jared Scott, Michael Kelliher (Executive Director, Cell Therapy Development and Operations, CAR-T), Michele Gaskell (Executive Director, Cell Therapy Development Operations), and Eelco Slagter (Executive Director, Integrated Scientific Operations, Research and Early Development). The Compliance function is led by Terra Buckley, JD as Chief Ethics and Compliance Officer, with Allison DeLaurentis (Executive Director, Compliance and Ethics Investigations) and Melissa McAfee (Executive Director, Global Cell Therapy, Quality Systems and Compliance); the Regulatory Compliance sub-function includes Christian Lamont (Executive Director, Automated Product Market Compliance), Kevin Tompkins, and Jim Shen; the Regulatory Reporting sub-function includes Linda Kamin; and the Trade Compliance sub-function includes Jacquelyn Mohns Goodall (Executive Director, Global Customs and Trade Compliance). The Operations function includes leaders such as Eric Luque, Maurice Bellfield, Megan Morin, Michael Sullivan, Maria Wagner, Kelsea Shoop (Executive Director, Global Patient Operations), Michel M. Russell, Sr., DML (Executive Director, Global Delivery Solutions, Intercompany Operations), Jason Pritchett (Executive Director, Cell Therapy Technical Operations, Drug Product), Susan Reese (Executive Director, Global Development Operations, Business Operations), Laurent Lehmann, Suzie Lee C., Linda Kamin, Chris Szymborski, Michael Kelliher, Michele Gaskell, Jim Shen, Eelco Slagter, and Shannon Higgins-Gruber. The Supply Chain function is led by Karin Shanahan as Executive Vice President, Chief Supply Chain and Operations Officer, with Jounal Shaikh (Executive Director, Cell Therapy End-to-End Supply Chain), Eric Pukszyn, and Nicholas Izzi (Executive Director, Bio and Pharma, Internal Site Supply Chain). The Procurement sub-function includes Paula Glickenhaus as Chief Procurement Officer, along with Edward Valverde, Troy Mathews, and Matthew P. Walls. The Strategic Sourcing sub-function under Procurement includes Edward Valverde, Rondu Vincent, and Matthew P. Walls. The Supplier Management sub-function includes Troy Mathews. The Supply Chain Strategy function includes Scott DeBruin (Executive Director, Supply Chain Competitiveness) and Angelica Vega (Executive Director, Strategic Supply Chain Product Leader). The Supply Chain Planning function includes Eric Pukszyn (Executive Director, Supply Chain Planning Digitization Excellence). The Manufacturing function includes Jason Pritchett and Michael Kelliher (Executive Director, Cell Therapy, Clinical Manufacturing). The Sustainability and ESG function includes Rondu Vincent as Executive Director of Responsible Sourcing and Sustainability. The Quality Assurance function includes Stephan O. Krause, PhD as Executive Director of Analytical Science and Technology, Cell Therapy Quality. The Product function includes Angelica Vega. The Clinical Services function includes Cristian Massacesi, M.D. as Executive Vice President, Chief Medical Officer, Development. The Engineering function includes Paul Fernandez as Executive Director of Development Engineering. The "Others" function includes Dina Elsheikh, MBA (Chief of Staff, Global Oncology Commercial Lead), Seemi Kazmi, Michel M. Russell, Sr., DML, and Michael Kelliher.